We study the cooperative bindingmechanisms of molecular glue degraders, specifically cereblon (CRBN)modulators targeting Ikaros family zinc finger 2 (IKZF2), a transcriptionfactor implicated in cancer immunotherapy. The gene discussed is CRBN; the disease is cancer.